Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Saccharin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACVR1 known ✓ | Q04771 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 7/20 | 0.96 |
| ▸ | CA9 | Q16790 | 7/20 | 0.96 |
| ▸ | CA2 | P00918 | 5/20 | 0.96 |
| ▸ | CA1 | P00915 | 4/20 | 0.96 |
| ▸ | CA7 | P43166 | 3/20 | 0.96 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.96 |
| ▸ | CA4 | P22748 | 2/20 | 0.96 |
| ▸ | USP2 | O75604 | 1/20 | 0.96 |
| ▸ | LMNA | P02545 | 1/20 | 0.96 |
| ▸ | BCHE | P06276 | 1/20 | 0.96 |
| ▸ | CA6 | P23280 | 1/20 | 0.96 |
| ▸ | CA5A | P35218 | 1/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.96 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.96 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | RET | P07949 | 2/20 | 0.53 |
| ▸ | GRK5 | P34947 | 2/20 | 0.53 |
| ▸ | TYRO3 | Q06418 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Saccharin SCHEMBL29453372 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL28835159 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL8728937 | 1.00 | CA12 (0.96) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL28192362 | 0.98 | CA12 (0.92) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL485939 | 0.98 | CA12 (0.92) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL29473301 | 0.98 | CA12 (0.92) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL28975671 | 0.98 | CA12 (0.92) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL1138067 | 0.98 | CA12 (0.92) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL29646267 | 0.98 | CA12 (0.92) | CA12CA9CA2CA1CA7 | |
| Saccharin SCHEMBL27530252 | 0.98 | CA12 (0.92) | CA12CA9CA2CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118221760-A | Preparation method of dysentery polysaccharide protein conjugate stock solution | 北京智飞绿竹生物制药有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118078981-A | Preparation method of double-protein carrier-based pentavalent meningococcal polysaccharide conjugate vaccine and product thereof | 成都康华生物制品股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| EP-4352194-A1 | A TABLET COMPOSITION | Unilever IP Holdings B.V. (NL) | 2024-04-17 | — | — | EP | claimed |
| CN-117618551-A | Method for preparing pneumococcal polysaccharide-protein conjugate | 北京智飞绿竹生物制药有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117441005-A | Tablet composition | 联合利华知识产权控股有限公司 | 2024-01-23 | — | — | CN | claimed |
| CN-113980104-B | Process method for purifying 15-valent pneumococcal polysaccharide protein conjugate by tangential flow ultrafiltration | 北京智飞绿竹生物制药有限公司 | 2023-08-22 | — | — | CN | claimed |
| WO-2022258413-A1 | A TABLET COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-12-15 | — | — | WO | claimed |
| CN-115282340-A | GelMA-based biological ink and preparation method and application thereof | 深圳大洲医学科技有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-115073544-A | PARP inhibitor pyrazoloquinine derivative and synthesis method thereof | 上海应用技术大学 | 2022-09-20 | — | — | CN | claimed |
| CN-113980104-A | Process method for purifying 15-valent pneumococcal polysaccharide protein conjugate by tangential flow ultrafiltration | 北京智飞绿竹生物制药有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-105101947-A | Dyeing method using iridoid compound and apparatus therefor | OREAL | 2015-11-25 | — | — | CN | claimed |
| WO-2014154871-A1 | DYEING PROCESS USING AN IRIDOID COMPOUND AND DEVICES FOR THE SAME | L'OREAL (FR) | 2014-10-02 | — | — | WO | claimed |
| EP-2690133-A1 | AQUEOUS-LIQUID-ABSORBABLE RESIN, AQUEOUS-LIQUID-ABSORBABLE COMPOSITION, AND ABSORBER MATERIAL AND ABSORBABLE OBJECT EACH PRODUCED USING SAME | Sanyo Chemical Industries, Ltd. (JP) | 2014-01-29 | — | — | EP | claimed |
| US-20050053911-A1 | Room temperature stable competent cells | GREENER ALAN L (US) | 2005-03-10 | — | — | US | claimed |
| EP-1328304-B1 | VERTEBRAL AUGMENTATION COMPOSITION | OSTEOTECH INC (US) | 2005-02-09 | — | — | EP | claimed |
| EP-0969816-B1 | PREPARATION OF POWDER AGGLOMERATES | SCHERING CORP (US) | 2004-12-15 | — | — | EP | claimed |
| EP-0646122-B1 | AN IMPROVED PROCESS FOR THE PREPARATION OF ALKYL GLYCOSIDES | COGNIS DEUTSCHLAND GMBH (DE) | 2003-12-17 | — | — | EP | claimed |
| EP-0805260-B1 | On-the-fly control of delayed borate-crosslinking of fracturing fluids | SOFITECH NV (BE) | 2003-06-11 | — | — | EP | claimed |
| WO-2002061111-A2 | ROOM TEMPERATURE STABLE COMPETENT CELLS | STRATAGENE (US) | 2002-08-08 | — | — | WO | claimed |
| EP-0048974-A1 | Process for producing saccharide oxides | Kao Corporation (JP) | 1982-04-07 | — | — | EP | claimed |